Company
A medical device company born in a hospital corridor.
Rethink Medical was created around a simple observation: some of the most widely used devices in healthcare are also the least questioned. T-Control® is our answer to one of them.
Mission
Rethinking what is taken for granted
We develop medical devices around patient experience, healthcare-professional needs and responsible use of healthcare resources. Our work starts with real clinical practice, not with technology looking for a problem.
T-Control® is an indwelling urinary catheter with an integrated flow-control valve designed to support controlled urinary drainage and simplify catheter management.
Clinical origin
Founded and led by professionals with hands-on nursing and clinical experience.
European roots
Based in the Canary Islands, Spain, operating across the European Union.
Quality management
Quality management system assessed under the MDR conformity assessment process for T-Control®.
Public backing
Supported by CDTI, SODECAN, ENISA, EIT Health and Horizon Europe programmes.
Trajectory
Milestones
2026
T-Control® reaches the market
Commercial launch of the CE-marked T-Control® urinary catheter begins.
2026
International commercialisation begins
First international distribution agreement signed for T-Control®.
2025
EAUN Scientific Research Award
First Scientific Research Prize at the European Association of Urology Nurses Congress.
2025
CE Marking under EU MDR
T-Control® obtained CE marking as a Class IIb medical device under Regulation (EU) 2017/745.
2024
Forbes Spain recognition
Rethink Medical founder Manuel Luque selected among Forbes Spain’s “24 Changemakers 2024”.
2024
Top 100 Startups in Spain
Selected by APTE.
2023
Canarias Destino Startup winner
Winner of the first edition of the programme.
2023
Clinical study begins
First patients enrolled in a clinical study of T-Control®.
2023
Scientific evidence published
First peer-reviewed studies evaluating the usability and potential benefits of T-Control® published in the International Journal of Urological Nursing.
2022
EIC Accelerator Seal of Excellence
Rethink Medical received a further Seal of Excellence under the EIC Accelerator, bringing the total number of European Commission Seals of Excellence received to four.
2021
EIT Health InnoStars finalist
Recognition of T-Control® within the European health innovation ecosystem.
2019–2020
Three Horizon 2020 Seals of Excellence
T-Control® received three Seals of Excellence from the European Commission following highly competitive Horizon 2020 SME Instrument evaluations. The proposals passed the European Commission assessment thresholds for excellence, impact, and quality and efficiency of implementation.
2019
Entrepreneurship recognition
Entrepreneur Award by Fundación MAPFRE Guanarteme.
2017
European Commission support
Selected under the SME Instrument Phase I programme.
2016
EIT Health Headstart
Selected for the EIT Health Headstart Programme.
2014
Rethink Medical is founded
Created in the Canary Islands to rethink urinary catheterisation through clinician-led innovation.
2012
The journey begins
First patent priority covering the core technology behind T-Control®.